US28176E1082
US28176E1082
Edwards Lifesciences Corporatio
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 6.067.600.000 | 5.439.500.000 | 11.5% |
| Cost of Revenue | 1.334.200.000 | 1.117.500.000 | 19.4% |
| Gross Profit | 4.733.400.000 | 4.322.000.000 | 9.5% |
| 3.097.200.000 | 2.841.900.000 | 9.0% | |
| Operating Income | 1.636.200.000 | 1.480.100.000 | 10.5% |
| Pretax Income | 1.272.900.000 | 1.548.100.000 | 17.8% |
| Net Income Common Stockholders | 1.073.500.000 | 4.174.600.000 | 74.3% |
| -- | -- | -- | |
| -- | -- | -- |